A Stanford-led phase 3 trial shows gene therapy skin grafts significantly heal chronic wounds in patients with severe ...

For patients with recessive dystrophic epidermolysis bullosa (RDEB), a one-time surgical application of prademagene ...

“Professor Mellerio brings an important clinical voice to the NETHERTON NOW series,” said Denise Carter, Co-Founder and Chief Operating Officer of Quoin Pharmaceuticals. “Her experience treating ...

A study finds that inhaled insulin is as effective as traditional injections for children with type 1 diabetes during ...

Krystal Biotech rises 4% after dosing begins in a phase III study of KB803 eye drops to treat rare DEB-related corneal damage ...